<VariationArchive VariationID="338302" VariationName="NM_000178.4(GSS):c.4del (p.Ala2fs)" VariationType="Deletion" Accession="VCV000338302" Version="14" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-15" DateCreated="2016-12-06" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="350932" VariationID="338302">
      <GeneList>
        <Gene Symbol="GSS" FullName="glutathione synthetase" GeneID="2937" HGNC_ID="HGNC:4624" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="34928432" stop="34956027" display_start="34928432" display_stop="34956027" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="33516235" stop="33543600" display_start="33516235" display_stop="33543600" Strand="-" />
          </Location>
          <OMIM>601002</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000178.4(GSS):c.4del (p.Ala2fs)</Name>
      <CanonicalSPDI>NC_000020.11:34951848:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q11.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="34951849" stop="34951849" display_start="34951849" display_stop="34951849" variantLength="1" positionVCF="34951848" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="33539652" stop="33539652" display_start="33539652" display_stop="33539652" variantLength="1" positionVCF="33539651" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A2fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1168" sequenceAccession="LRG_1168" change="g.9179del">
            <Expression>LRG_1168:g.9179del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1168t1" sequenceAccession="LRG_1168t1" change="c.4del">
            <Expression>LRG_1168t1:c.4del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1168p1" sequenceAccession="LRG_1168p1" change="p.Ala2fs">
            <Expression>LRG_1168p1:p.Ala2fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.33539653del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.33539653del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.34951850del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.34951850del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008848.2" sequenceAccession="NG_008848" sequenceVersion="2" change="g.9179del">
            <Expression>NG_008848.2:g.9179del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016984.2" sequenceAccession="NG_016984" sequenceVersion="2" change="g.950del">
            <Expression>NG_016984.2:g.950del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000178.4" sequenceAccession="NM_000178" sequenceVersion="4" change="c.4del" MANESelect="true">
            <Expression>NM_000178.4:c.4del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000169.1" sequenceAccession="NP_000169" sequenceVersion="1" change="p.Ala2fs">
            <Expression>NP_000169.1:p.Ala2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322494.1" sequenceAccession="NM_001322494" sequenceVersion="1" change="c.4del">
            <Expression>NM_001322494.1:c.4del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309423.1" sequenceAccession="NP_001309423" sequenceVersion="1" change="p.Ala2fs">
            <Expression>NP_001309423.1:p.Ala2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322495.1" sequenceAccession="NM_001322495" sequenceVersion="1" change="c.4del">
            <Expression>NM_001322495.1:c.4del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001309424.1" sequenceAccession="NP_001309424" sequenceVersion="1" change="p.Ala2fs">
            <Expression>NP_001309424.1:p.Ala2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA9826205" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="601002.0002" DB="OMIM" />
        <XRef Type="rs" ID="752560204" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000178.4(GSS):c.4del (p.Ala2fs) AND Inherited glutathione synthetase deficiency" Accession="RCV000345182" Version="12">
        <ClassifiedConditionList TraitSetID="2349">
          <ClassifiedCondition DB="MedGen" ID="CN030166">Inherited glutathione synthetase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-01-28" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000178.4(GSS):c.4del (p.Ala2fs) AND not provided" Accession="RCV001782855" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000178.4(GSS):c.4del (p.Ala2fs) AND Glutathione synthetase deficiency with 5-oxoprolinuria" Accession="RCV004567866" Version="1">
        <ClassifiedConditionList TraitSetID="66012">
          <ClassifiedCondition DB="MedGen" ID="C0398746">Glutathione synthetase deficiency with 5-oxoprolinuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-28" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2016-12-06" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(3); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">12638941</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15717202</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8896573</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(3); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-09-14">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-09-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-03-16">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="66012" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="55966" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PYROGLUTAMIC ACIDURIA</ElementValue>
                <XRef Type="MIM" ID="266130" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">5-Oxoprolinuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glutathione synthetase deficiency with 5-oxoprolinuria</ElementValue>
                <XRef ID="MONDO:0009947" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Reduced glutathione synthetase level</ElementValue>
                <XRef ID="HP:0003343" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gluthathione synthetase deficiency</ElementValue>
                <XRef ID="5-Oxoprolinuria/52" DB="Genetic Alliance" />
                <XRef ID="234589002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GSSD</ElementValue>
                <XRef Type="MIM" ID="266130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17330" />
                <XRef ID="17330" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="289846" DB="Orphanet" />
              <XRef ID="C0398746" DB="MedGen" />
              <XRef ID="MONDO:0009947" DB="MONDO" />
              <XRef Type="MIM" ID="266130" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003343" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2349" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1384" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inherited glutathione synthetase deficiency</ElementValue>
                <XRef ID="MONDO:0017909" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10047" />
                <XRef ID="10047" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="32" DB="Orphanet" />
              <XRef ID="CN030166" DB="MedGen" />
              <XRef ID="MONDO:0017909" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29269" SubmissionDate="2015-08-12" DateLastUpdated="2023-09-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601002.0002_GLUTATHIONE SYNTHETASE DEFICIENCY" title="GSS, 1-BP DEL, NT3/4G _GLUTATHIONE SYNTHETASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV000029269" DateUpdated="2023-09-03" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp deletion in the GSS gene (3(4)delG) that was found in compound heterozygous state in 2 brothers with 5-oxoprolinuria (GSSD; 266130) by Shi et al. (1996), see 601002.0001.</Attribute>
              <Citation>
                <ID Source="PubMed">8896573</ID>
              </Citation>
              <XRef DB="OMIM" ID="266130" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GSS" />
          </GeneList>
          <Name>GSS, 1-BP DEL, NT3/4G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, NT3/4G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601002.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLUTATHIONE SYNTHETASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1362118" SubmissionDate="2018-01-25" DateLastUpdated="2023-09-03" DateCreated="2018-03-20">
        <ClinVarSubmissionID localKey="NM_000178.2:c.4delG|MedGen:CN003017" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000695766" DateUpdated="2023-09-03" DateCreated="2018-03-20" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-09-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8896573</ID>
          </Citation>
          <Comment>Variant summary: The c.4delG (p.Ala2Profs) variant in GSS gene is a nonsense change that results in the loss of the 460 amino acids of GSS (~98%). This change is predicted to cause loss of normal protein function through protein truncation or nonsense-mediated mRNA decay. The results of functional showed less than 10% GSS activity in pts fibroblasts as well as in bacterial expression system. . The variant is present in the large control population dataset of ExAC at a low frequency 0.0002 (25/120304 chrs tested), exclusively in individuals of European descent (0.00038; 15/66140).The latter frequency does not exceed the maximal expected frequency of a pathogenic allele (0.003) in this gene. The variant of interest has been reported in two brothers presented with oxoprolinuria, metabolic acidosis, haemolytic anemia and mental retardation. Taking together, the variant was classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GSS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="752560204" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000178.2:c.4delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN003017" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="747142" SubmissionDate="2019-02-01" DateLastUpdated="2023-09-03" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="831065" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000433621" DateUpdated="2023-09-03" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8896573</ID>
          </Citation>
          <Comment>The GSS c.4delG (p.Ala2ProfsTer14) variant results in a frameshift, and is predicted to result in premature termination of the protein. The p.Ala2ProfsTer14 variant has been reported in one study in which it was found in a compound heterozygous state with a missense variant in two siblings with glutathione synthetase (GS) deficiency. Control data are unavailable for this variant which is reported at a frequency of 0.0004 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional studies in E. coli and yeast demonstrate that the variants result in 2% of expression levels and 10% GSS activity as compared to wildtype (Shi et al. 1996). Due to the potential impact of frameshift variants and supporting evidence, the p.Ala2ProfsTer14 variant is classified as a variant of unknown significance but suspicious for pathogenicity for glutathione synthetase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GSS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="20" alternateAllele="G" referenceAllele="GC" start="33539651" stop="33539652" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000178.2:c.4delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="266130" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3959885" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="27ec5f29e965ff4d9e4b8ed62d5fbafb7587b2477f4e384af781f55eeeb646c6|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002024924" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="4" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000178.4:c.4del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8238700" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="1965462|MedGen:C0398746" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004448841" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12638941</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15717202</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8896573</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala2Profs*14) in the GSS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GSS are known to be pathogenic (PMID: 12638941, 15717202). This variant is present in population databases (rs752560204, gnomAD 0.5%). This premature translational stop signal has been observed in individual(s) with gluthathione synthetase deficiency (PMID: 8896573). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 338302). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GSS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.33539652del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0398746" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="747142" TraitType="Disease" MappingType="XRef" MappingValue="266130" MappingRef="OMIM">
        <MedGen CUI="C0398746" Name="Glutathione synthetase deficiency with 5-oxoprolinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8238700" TraitType="Disease" MappingType="XRef" MappingValue="C0398746" MappingRef="MedGen">
        <MedGen CUI="C0398746" Name="Glutathione synthetase deficiency with 5-oxoprolinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="29269" TraitType="Disease" MappingType="Name" MappingValue="GLUTATHIONE SYNTHETASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C0398746" Name="Glutathione synthetase deficiency with 5-oxoprolinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3959885" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1362118" TraitType="Finding" MappingType="XRef" MappingValue="CN003017" MappingRef="MedGen">
        <MedGen CUI="CN030166" Name="Inherited glutathione synthetase deficiency" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001525811</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

